Optimize Financial’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Sell
1,638
-5
-0.3% -$1.31K 0.16% 178
2026
Q1
$438K Buy
1,643
+101
+7% +$27.3K 0.22% 158
2025
Q4
$387K Buy
1,542
+20
+1% +$5.31K 0.19% 218
2025
Q3
$437K Buy
+1,522
New +$408K 0.23% 171

Other funds holding LH

Optimize Financial's LH Position: Q2 2026 in Review

Optimize Financial reduced its Labcorp (LH) stake by 0.3% in Q2 2026, selling an estimated $1.31K and leaving 1,638 shares worth $459K. The position accounts for 0.16% of the portfolio, ranked #178.

Optimize Financial first reported a position in LH in Q3 2025 and has held it in 4 quarters since. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Optimize Financial held 1,638 shares of Labcorp worth $459K as of Q2 2026.
  • Optimize Financial sold 5 Labcorp shares in Q2 2026, an estimated $1.31K.
  • Labcorp made up 0.16% of Optimize Financial's portfolio in Q2 2026, its #178 holding.
  • Optimize Financial first reported a position in Labcorp in Q3 2025 and has held it in 4 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Optimize Financial's 13F filing for Q2 2026, filed 27 Aug 2026.